Yubo International Biotech (YBGJ) Stock Price, News & Analysis

Company Overview

Yubo International Biotech Limited, through its subsidiaries, focuses on the research and development, and application of endometrial stem cells. It offers healthcare products for respiratory system, skincare products, hair care products, healthy beverages, and male and female personal care products; and stem cell related services, including cell testing and health management consulting services under the VIVCELL brand. The company is headquartered in Beijing, China.

Key Stats

• Today's Range: $0.04 to $0.04
• 50-Day Range: $0.04 to $0.14
• 52-Week Range: $0.03 to $0.54
• Volume: N/A
• Average Volume: 248,571 shs
• Market Capitalization: $4.30 million
• P/E Ratio: N/A
• Dividend Yield: N/A
• Price Target: N/A
• Consensus Rating: N/A

YBGJ Stock Analysis - Frequently Asked Questions

How have YBGJ shares performed this year?

Yubo International Biotech's stock was trading at $0.0347 at the start of the year. Since then, YBGJ shares have increased by 3.5% and is now trading at $0.0359.

How do I buy shares of Yubo International Biotech?

Shares of YBGJ stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.

What other stocks do shareholders of Yubo International Biotech own?

Based on aggregate information from My MarketBeat watchlists, some other companies that Yubo International Biotech investors own include AutoZone (AZO), Intel (INTC), TJX Companies (TJX), Abacus Health Products (ABAHF), Avino Silver & Gold Mines (ASM), Bank of America (BAC) and Cal-Maine Foods (CALM).

Company Calendar

• Today: 8/09/2025
• Fiscal Year End: 12/31/2025

Industry, Sector and Symbol

• Stock Exchange: OTCMKTS
• Sector: Medical
• Industry: MED INSTRUMENTS
• Sub-Industry: Medical Equipment
• Current Symbol: OTCMKTS:YBGJ
• CIK: 895464
• Web: www.yubogroup.com
• Phone: (640) 677-6010
• Fax: 516-595-1159
• Employees: 20
• Year Founded: N/A

Profitability

• EPS (Trailing Twelve Months): ($0.01)
• Trailing P/E Ratio: N/A
• Forward P/E Ratio: N/A
• P/E Growth: N/A
• Net Income: -$1.77 million
• Net Margins: N/A
• Pretax Margin: -57,118.15%
• Return on Equity: N/A
• Return on Assets: -124.79%

Debt

• Debt-to-Equity Ratio: N/A
• Current Ratio: 0.14
• Quick Ratio: 0.14

Sales & Book Value

• Annual Sales: N/A
• Price / Sales: N/A
• Cash Flow: N/A
• Price / Cash Flow: N/A
• Book Value: ($0.03) per share
• Price / Book: -1.20

Miscellaneous

• Outstanding Shares: 119,821,000
• Free Float: 37,744,000
• Market Cap: $4.30 million
• Optionable: Not Optionable
• Beta: 3.74